{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:11:13Z","timestamp":1777381873253,"version":"3.51.4"},"reference-count":29,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2025,10,22]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Psychological distress is a common yet under-recognised complication in cancer patients, significantly affecting quality of life, treatment adherence and clinical outcomes. Patients with oral cavity cancer are particularly susceptible due to the visible disfigurement caused by the disease, speech and swallowing impairments and associated social stigma, which contribute to heightened levels of anxiety, depression and social withdrawal. This study aimed to evaluate and compare the efficacy and safety of olanzapine and mirtazapine in managing psychological distress in patients with oral cavity cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 144 patients fulfilling the inclusion criteria were randomly allocated into two groups of 77 patients each. Group M received the tablet mirtazapine 15 mg\/day orally; Group O received the tablet olanzapine 5 mg\/day orally at bed time. All patients were assessed by using the Hospital Anxiety and Depression Score at the time of the first visit, then the follow-up visit at second and fourth weeks. Data were collected and analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both mirtazapine and olanzapine led to significant reductions in anxiety and depression scores over time, with p&lt;0.001. Mirtazapine reduced anxiety scores from 14.10 at admission to 10.28 in the fourth week, while olanzapine reduced them from 14.08 to 10.97. For depression, mirtazapine showed a decrease from 14.07 to 10.24, compared with a reduction from 14.01 to 10.98 with olanzapine. The overall drug effect was statistically significant, though no significant interaction between drug and time was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both mirtazapine and olanzapine effectively reduced anxiety and depression, with mirtazapine showing greater efficacy. Mirtazapine may be preferred, though olanzapine remains a viable alternative.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2025-005706","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T19:30:15Z","timestamp":1764876615000},"page":"687-695","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Mirtazapine and olanzapine for cancer-related psychological distress in advanced oral cancer: efficacy and safety prospective study"],"prefix":"10.1136","volume":"16","author":[{"given":"Yogendra","family":"Singhal","sequence":"first","affiliation":[{"name":"Palliative Medicine, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9297-6734","authenticated-orcid":false,"given":"Surendra Kumar","family":"Pingoliya","sequence":"additional","affiliation":[{"name":"Palliative Medicine, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan","family":"Gaurav R","sequence":"additional","affiliation":[{"name":"Palliative Medicine, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreeharsh","family":"Saji","sequence":"additional","affiliation":[{"name":"Palliative Medicine, Sawai Man Singh Medical College and Hospital, Jaipur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2026042802201394000_16.3.687.1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.179"},{"key":"2026042802201394000_16.3.687.2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.26416\/Psih.77.2.2024.9740","article-title":"The benefits of early psychiatric treatment in patients with oncological pathology","volume":"2","author":"Florescu","year":"2024","journal-title":"PsihiatruRo"},{"key":"2026042802201394000_16.3.687.3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.oraloncology.2009.01.001","article-title":"Distress and care needs in newly diagnosed oral cavity cancer patients receiving surgery","volume":"45","author":"Chen","year":"2009","journal-title":"Oral Oncol"},{"key":"2026042802201394000_16.3.687.4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/9781119842958.ch4.1","article-title":"Bacterial Infections of the Oral and Maxillofacial Region","volume":"4","author":"Kuriyama","year":"2025","journal-title":"Oral Maxillofac Surg"},{"key":"2026042802201394000_16.3.687.5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00152192-200501000-00009","article-title":"Breaking the cycle of stigmatization: managing the stigma of incontinence in social interactions","volume":"32","author":"Garcia","year":"2005","journal-title":"Journal of Wound Ostomy & Continence Nursing"},{"key":"2026042802201394000_16.3.687.6","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1561916","article-title":"Can social isolation alleviate symptoms of anxiety and depression disorders?","volume":"16","author":"Pe\u00e7anha","year":"2025","journal-title":"Front Psychiatry"},{"key":"2026042802201394000_16.3.687.7","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0048"},{"key":"2026042802201394000_16.3.687.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.4825"},{"key":"2026042802201394000_16.3.687.9","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2174\/0929867327666200907141452","article-title":"Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates","volume":"28","author":"Antoszczak","year":"2021","journal-title":"Curr Med Chem"},{"key":"2026042802201394000_16.3.687.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00146-7"},{"key":"2026042802201394000_16.3.687.11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/j.1875-9114.1997.tb03674.x","article-title":"Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects","volume":"17","author":"Stimmel","year":"1997","journal-title":"Pharmacotherapy"},{"key":"2026042802201394000_16.3.687.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05244-8"},{"key":"2026042802201394000_16.3.687.13","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1993"},{"key":"2026042802201394000_16.3.687.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2001.tb00198.x"},{"key":"2026042802201394000_16.3.687.15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v62n07a02","article-title":"Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study","volume":"62","author":"Narendran","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"2026042802201394000_16.3.687.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0425-1"},{"key":"2026042802201394000_16.3.687.17","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200828020-00005"},{"key":"2026042802201394000_16.3.687.18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.41.4.356"},{"key":"2026042802201394000_16.3.687.19","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2169\/internalmedicine.4341-19","article-title":"The Quality of Life of Patients with Suspected Lung Cancer before and after Bronchoscopy and the Effect of Mirtazapine on the Depressive Status","volume":"59","author":"Kaneko","year":"2020","journal-title":"Intern Med"},{"key":"2026042802201394000_16.3.687.20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jpainsymman.2021.05.017","article-title":"Mirtazapine in Cancer-Associated Anorexia and Cachexia: A Double-Blind Placebo-Controlled Randomized Trial","volume":"62","author":"Hunter","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"2026042802201394000_16.3.687.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12904-022-00976-7","article-title":"What is the effectiveness and safety of mirtazapine versus escitalopram in alleviating cancer-associated poly-symptomatology (the MIR-P study)? A mixed-method randomized controlled trial protocol","volume":"21","author":"Economos","year":"2022","journal-title":"BMC Palliat Care"},{"key":"2026042802201394000_16.3.687.22","doi-asserted-by":"crossref","DOI":"10.4103\/1735-1995.192504","article-title":"Efficacy of olanzapine in symptom relief and quality of life in gastric cancer patients receiving chemotherapy","volume":"21","author":"Nikbakhsh","year":"2016","journal-title":"J Res Med Sci"},{"key":"2026042802201394000_16.3.687.23","doi-asserted-by":"publisher","DOI":"10.21037\/apm-22-1167"},{"key":"2026042802201394000_16.3.687.24","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012331","article-title":"Olanzapine with ondansetron and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in lung cancer","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2026042802201394000_16.3.687.25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.48095\/ccko2022276","article-title":"Olanzapine in oncology palliative care","volume":"35","author":"\u0160oukalov\u00e1","year":"2022","journal-title":"Klin Onkol"},{"key":"2026042802201394000_16.3.687.26","first-page":"1597","article-title":"What is the evidence for mirtazapine in treating cancer-related symptomatology? A systematic review","volume":"28","author":"Economos","year":"2020","journal-title":"Support Care Cancer"},{"key":"2026042802201394000_16.3.687.27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34618-x","article-title":"Olanzapine plus aprepitant, palonosetron, and dexamethasone for nausea and vomiting in patients with breast cancer receiving anthracycline: A retrospective study","volume":"8","author":"Kawazoe","year":"2018","journal-title":"Sci Rep"},{"key":"2026042802201394000_16.3.687.28","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.21037\/apm-20-1784","article-title":"Effects of 5-mg dose of olanzapine for breakthrough nausea and vomiting in patients receiving carboplatin-based chemotherapy: a prospective trial","volume":"10","author":"Maeda","year":"2021","journal-title":"Ann Palliat Med"},{"key":"2026042802201394000_16.3.687.29","first-page":"2649","article-title":"Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines","volume":"23","author":"Naing","year":"2015","journal-title":"Support Care Cancer"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-005706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:22:11Z","timestamp":1777368131000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-005706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,28]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/spcare-2025-005706"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-005706","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]}}}